Search

Search Constraints

You searched for: Author/Creator Chou, Jonathan

Search Results

3. Differential treatment outcomes in BRCA1/2‐, CDK12‐, and ATM‐mutated metastatic castration‐resistant prostate cancer. Issue 12 (10th March 2021)

4. E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression. (23rd October 2014)

5. Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. Issue 6 (9th December 2021)

6. Reliability of real-world data for diagnosis of metastatic prostate cancer. Issue 28 (1st October 2022)

9. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. Issue 5 (12th May 2021)

10. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. Issue 5 (12th May 2021)